|
ProMetic’s PBI-4050 Delivers New Positive Preclinical Results in Liver …
MENAFN.COM Liver transplantation is the only treatment available for patients with advanced stage of fibrosis. About ProMetic Life Sciences Inc. ProMetic Life Sciences Inc. (www.prometic.com) is a long established biopharmaceutical company with globally … |
|
Novel prediction model improves patient outcomes after paracetamol-induced …
News-Medical.net … the European Association for the Study of the Liver and Associate Professor of Medicine, University of Vienna, Austria commented: “Acute liver failure is a devastating condition that triggers a cascade of events that can lead to multiple organ … New prediction model to improve patient survival after paracetamol-related …Medical Xpress |
Know Your Madisonian: Dr. Dan ResnickMadison.comA: We are currently involved in some stem cell transplant studies for multiple sclerosis and we have participated in other drug studies for spinal cord injury, but there is really no medical game-changer …
BioLineRx Announces Investigator-Initiated Study for Novel Chronic Myeloid …Business Wire (press release)Pre-clinical studies show that BL-8040 is efficient, both alone and in combination with anti-cancer drugs such as Rituximab, Imatinib and Bortezo…
|
Your Good Health: Therapies for low bone density can be effective
Times Colonist Unfortunately, we do not have any way to reliably prevent Type 1 diabetes, although studies with drugs that modulate the immune system have shown early promise. Pancreas transplantation, and even islet cell transplant, can “cure” Type 1 diabetes … |
Optimism tied to lower risk of heart failureTimes of IndiaResearchers from the University of Michigan and Harvard University found that compared to the least optimistic people in the study, the most optimistic people had a 73 per cent reduced risk of h…
|
Lenalidomide plus rituximab induced durable responses in NHL
Healio The combination of lenalidomide and rituximab produced durable responses in a cohort of patients with relapsed/refractory or indolent non-Hodgkin’s lymphoma, according to results of a phase 2 study. Thirty patients received weekly rituximab (Rituxan, … |
Combination therapy with rituximab may benefit elderly patients with DLBCLHealioIn elderly patients with diffuse large B-cell lymphoma, a combination therapy regimen that includes rituximab appears to yield successful response rates, according to recen…
India Today |
Who’s making heart shapes on Mars?
India Today Who’s making heart shapes on Mars? IndiaToday.in April 10, 2014 | UPDATED 15:34 IST. The heart shape is located south of Ascraeus Mons, which is a large volcano within the Tharsis volcanic plateau. (Courtesy: NASA). Strange things are being seen on … |
Mayo Clinic research shows RA patients more likely to develop chronic kidney …News-Medical.netRheumatoid arthritis patients are likelier than the average person to develop chronic kidney disease, and more severe inflammation in the first year of rheu…